Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: J Neurochem. 2014 Mar 27;130(1):41–49. doi: 10.1111/jnc.12710

Fig. 3.

Fig. 3

Blockade of KCa3.1 inhibits TGF-β-induced CSPG expression. (A) Representative western blot showing CSPG expression in conditioned medium (CM) harvested from astrocytes treated with TGF-β (10 ng/ml) for 5 days in the presence of TRAM-34 (1, 10μM). (B) Representative western blot showing CSPG expression in cell lysates (LY) harvested from astrocytes treated with TGF-β (10 ng/ml) for 5 days in the presence of TRAM-34 (1, 10μM). Quantification of western blot for CS-56 immunoreactivity (n = 3). Data are presented as means ± SEM. ## p < 0.01, ### p < 0.001 versus control, * p < 0.05, ** p < 0.01, *** p < 0.001 versus TGF-β alone. Con: control.